Apricus Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch APRI and buy or sell other stocks, ETFs, and their options commission-free!

About APRI

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of products that address significant unmet needs in Central Nervous System (CNS) disorders and other rare disorders. 

CEO
Raj Mehra, PhD, MBA
CEORaj Mehra, PhD, MBA
Employees
Employees
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1987
Founded1987
Employees
Employees

APRI Key Statistics

Market cap
10.48M
Market cap10.48M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
Dividend yield
Average volume
334.32K
Average volume334.32K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$49.80
52 Week high$49.80
52 Week low
$0.94
52 Week low$0.94

Stock Snapshot

The current Apricus Biosciences(APRI) stock price is $0.85, with a market capitalization of 10.48M. The stock trades at a price-to-earnings (P/E) ratio of -0.08.

On 2025-12-09, Apricus Biosciences(APRI) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 334.32K.

Over the past 52 weeks, Apricus Biosciences(APRI) stock has traded between a high of $49.80 and a low of $0.94.

Over the past 52 weeks, Apricus Biosciences(APRI) stock has traded between a high of $49.80 and a low of $0.94.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.